JP2022500456A5 - - Google Patents
Info
- Publication number
- JP2022500456A5 JP2022500456A5 JP2021514419A JP2021514419A JP2022500456A5 JP 2022500456 A5 JP2022500456 A5 JP 2022500456A5 JP 2021514419 A JP2021514419 A JP 2021514419A JP 2021514419 A JP2021514419 A JP 2021514419A JP 2022500456 A5 JP2022500456 A5 JP 2022500456A5
- Authority
- JP
- Japan
- Prior art keywords
- crystal form
- compound
- cancer
- chemical formula
- group
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862731500P | 2018-09-14 | 2018-09-14 | |
| US62/731,500 | 2018-09-14 | ||
| PCT/IB2019/057720 WO2020053816A1 (en) | 2018-09-14 | 2019-09-12 | Crystalline forms of a quinazole compound and its hydrochloride salts |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022500456A JP2022500456A (ja) | 2022-01-04 |
| JP2022500456A5 true JP2022500456A5 (https=) | 2022-09-22 |
| JPWO2020053816A5 JPWO2020053816A5 (https=) | 2022-09-22 |
| JP7554030B2 JP7554030B2 (ja) | 2024-09-19 |
Family
ID=69776732
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021513941A Pending JP2022500416A (ja) | 2018-09-14 | 2019-09-12 | がんを処置するためのキットおよび方法 |
| JP2021514419A Active JP7554030B2 (ja) | 2018-09-14 | 2019-09-12 | キナゾリン化合物及びその塩酸塩の結晶形 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021513941A Pending JP2022500416A (ja) | 2018-09-14 | 2019-09-12 | がんを処置するためのキットおよび方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20220040180A1 (https=) |
| EP (2) | EP3849557A4 (https=) |
| JP (2) | JP2022500416A (https=) |
| KR (2) | KR102802129B1 (https=) |
| CN (2) | CN112770758A (https=) |
| AR (2) | AR116669A1 (https=) |
| AU (2) | AU2019337640A1 (https=) |
| BR (2) | BR112021004527A2 (https=) |
| CA (2) | CA3110369A1 (https=) |
| IL (2) | IL281168A (https=) |
| MX (2) | MX2021002875A (https=) |
| PH (2) | PH12021550432A1 (https=) |
| PY (2) | PY1976960A (https=) |
| SG (2) | SG11202102006YA (https=) |
| TW (2) | TW202027750A (https=) |
| UY (2) | UY38374A (https=) |
| WO (2) | WO2020056156A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021004527A2 (pt) | 2018-09-14 | 2021-06-08 | Spectrum Pharmaceuticals, Inc. | kits e métodos para tratamento contra câncer |
| JP2023503318A (ja) | 2019-11-21 | 2023-01-27 | ファルマ、マール、ソシエダード、アノニマ | ルルビネクテジン製剤で小細胞肺がんを処置する方法 |
| CN114642728A (zh) * | 2021-06-02 | 2022-06-21 | 德琪(浙江)医药科技有限公司 | mTOR抑制剂的制药用途及其药物组合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5069905B2 (ja) * | 2003-01-21 | 2012-11-07 | アプテュイト （ウエスト ラファイエット）、エルエルシー | 新規な共結晶化 |
| KR100735639B1 (ko) * | 2004-12-29 | 2007-07-04 | 한미약품 주식회사 | 암세포 성장 억제 효과를 갖는 퀴나졸린 유도체 및 이의제조방법 |
| MX2007010399A (es) * | 2005-02-26 | 2007-09-25 | Astrazeneca Ab | Derivados de quinazolina en la forma de inhibidores de cinasa de tirosina. |
| CN101454302A (zh) * | 2006-05-31 | 2009-06-10 | 艾博特公司 | 用作大麻素受体配位体的噻唑化合物及其用途 |
| CA2659307A1 (en) | 2006-07-28 | 2008-01-31 | Synthon B.V. | Crystalline erlotinib |
| US8349855B2 (en) * | 2007-02-21 | 2013-01-08 | Natco Pharma Limited | Polymorphs of erlotinib hydrochloride and method of preparation |
| TWI377944B (en) | 2007-06-05 | 2012-12-01 | Hanmi Holdings Co Ltd | Novel amide derivative for inhibiting the growth of cancer cells |
| KR101217526B1 (ko) * | 2010-06-11 | 2013-01-02 | 한미사이언스 주식회사 | 아마이드 유도체 또는 이의 약학적으로 허용 가능한 염을 포함하는 약제학적 조성물 |
| KR101317809B1 (ko) * | 2011-06-07 | 2013-10-16 | 한미약품 주식회사 | 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물 |
| KR101272613B1 (ko) * | 2011-10-05 | 2013-06-10 | 한미사이언스 주식회사 | 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온 염산염의 제조 방법 및 이에 사용되는 중간체 |
| CN105209456B (zh) * | 2013-03-06 | 2018-05-08 | 阿斯利康(瑞典)有限公司 | 表皮生长因子受体的活化突变形式的喹唑啉抑制剂 |
| WO2015154725A1 (zh) * | 2014-04-11 | 2015-10-15 | 四川海思科制药有限公司 | 喹唑啉衍生物及其制备方法和在医药上的应用 |
| CN106588943B (zh) * | 2015-10-19 | 2018-10-16 | 广东东阳光药业有限公司 | 一种egfr抑制剂的盐、晶型及其用途 |
| US11672801B2 (en) * | 2016-10-19 | 2023-06-13 | United States Government As Represented By The Department Of Veterans Affairs | Compositions and methods for treating cancer |
| MA46852A (fr) * | 2016-11-17 | 2019-09-25 | Univ Texas | Composés à activité antitumorale contre des cellules cancéreuses porteuses de mutations egfr ou her2 exon 20 |
| BR112021004527A2 (pt) | 2018-09-14 | 2021-06-08 | Spectrum Pharmaceuticals, Inc. | kits e métodos para tratamento contra câncer |
-
2019
- 2019-09-12 BR BR112021004527-9A patent/BR112021004527A2/pt not_active Application Discontinuation
- 2019-09-12 SG SG11202102006YA patent/SG11202102006YA/en unknown
- 2019-09-12 CA CA3110369A patent/CA3110369A1/en active Pending
- 2019-09-12 WO PCT/US2019/050843 patent/WO2020056156A1/en not_active Ceased
- 2019-09-12 JP JP2021513941A patent/JP2022500416A/ja active Pending
- 2019-09-12 EP EP19860538.8A patent/EP3849557A4/en not_active Withdrawn
- 2019-09-12 MX MX2021002875A patent/MX2021002875A/es unknown
- 2019-09-12 JP JP2021514419A patent/JP7554030B2/ja active Active
- 2019-09-12 AU AU2019337640A patent/AU2019337640A1/en not_active Abandoned
- 2019-09-12 US US17/275,290 patent/US20220040180A1/en not_active Abandoned
- 2019-09-12 AU AU2019340598A patent/AU2019340598B2/en active Active
- 2019-09-12 US US17/275,382 patent/US11883402B2/en active Active
- 2019-09-12 KR KR1020217010957A patent/KR102802129B1/ko active Active
- 2019-09-12 CN CN201980060160.6A patent/CN112770758A/zh active Pending
- 2019-09-12 WO PCT/IB2019/057720 patent/WO2020053816A1/en not_active Ceased
- 2019-09-12 KR KR1020217010772A patent/KR20210061371A/ko not_active Withdrawn
- 2019-09-12 CA CA3111062A patent/CA3111062A1/en active Pending
- 2019-09-12 MX MX2021002876A patent/MX2021002876A/es unknown
- 2019-09-12 SG SG11202101712XA patent/SG11202101712XA/en unknown
- 2019-09-12 EP EP19859287.5A patent/EP3849964A4/en active Pending
- 2019-09-12 BR BR112021004546-5A patent/BR112021004546A2/pt not_active IP Right Cessation
- 2019-09-12 CN CN201980060170.XA patent/CN112823153A/zh active Pending
- 2019-09-16 TW TW108133290A patent/TW202027750A/zh unknown
- 2019-09-16 AR ARP190102610A patent/AR116669A1/es not_active Application Discontinuation
- 2019-09-16 UY UY0001038374A patent/UY38374A/es unknown
- 2019-09-16 UY UY0001038375A patent/UY38375A/es not_active Application Discontinuation
- 2019-09-16 TW TW108133291A patent/TW202023562A/zh unknown
- 2019-09-16 PY PY201901976960A patent/PY1976960A/es unknown
- 2019-09-16 AR ARP190102611A patent/AR116406A1/es not_active Application Discontinuation
- 2019-09-16 PY PY201901976957A patent/PY1976957A/es unknown
-
2021
- 2021-03-01 IL IL281168A patent/IL281168A/en unknown
- 2021-03-01 PH PH12021550432A patent/PH12021550432A1/en unknown
- 2021-03-01 IL IL281167A patent/IL281167A/en unknown
- 2021-03-03 PH PH12021550456A patent/PH12021550456A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7710356B2 (ja) | ５，１０－メチレン－（６ｒ）－テトラヒドロ葉酸のヘミ硫酸塩 | |
| ES2702450T3 (es) | Derivados de la quinoxalina útiles como moduladores de la FGFR quinasa | |
| JP6905662B2 (ja) | 置換キノリン化合物の結晶形およびその医薬組成物 | |
| JP2022500456A5 (https=) | ||
| JP2020514271A5 (https=) | ||
| AU2019218186B2 (en) | Urea-substituted aromatic ring-linked dioxinoquinoline compounds, preparation method and uses thereof | |
| JP2010525057A5 (https=) | ||
| JP2009515992A5 (https=) | ||
| EP2651899A2 (en) | Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof | |
| CA2917096A1 (en) | Sulfoximine substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives and their use as cdk9 kinase inhibitors | |
| NZ739185A (en) | Compounds and pharmaceutical composition associated with ubiquitination-proteasome system | |
| JP2010523700A5 (https=) | ||
| JP2018533608A (ja) | 置換キノリン化合物の結晶形およびその医薬組成物 | |
| JP2012518598A5 (https=) | ||
| JP2018529643A5 (https=) | ||
| JP7554030B2 (ja) | キナゾリン化合物及びその塩酸塩の結晶形 | |
| CN109311817B (zh) | 取代的含氮芳环化合物及其应用 | |
| EP3101020A1 (en) | Deuterated quinazolinone compound and pharmaceutical composition comprising same | |
| JPWO2020053816A5 (https=) | ||
| JP5161072B2 (ja) | オーロラａ選択的阻害作用を有する新規アミノピリジン誘導体 | |
| CA3011289A1 (en) | Compounds for inhibiting cancer and virus | |
| CN106146478B (zh) | 三嗪衍生物类间变性淋巴瘤激酶抑制剂 | |
| JP7018224B2 (ja) | 尿素置換芳香族環結合ジオキシノキノリン系化合物、その調製方法および使用 | |
| RU2021110277A (ru) | Наборы и способы для лечения онкологических заболеваний | |
| RU2605400C1 (ru) | ПРОИЗВОДНЫЕ 1-(3-АМИНОФЕНИЛ)-6,8-ДИМЕТИЛ-5-(4-ИОД-2-ФТОР-ФЕНИЛАМИНО)-3-ЦИКЛОПРОПИЛ-1H,6H-ПИРИДО[4,3-d]ПИРИМИДИН-2,4,7-ТРИОНА В КАЧЕСТВЕ ИНГИБИТОРОВ МЕК1/2 |